FLAG Therapeutics Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $72.5K
Latest Deal Amount
  • Investors
  • 1

FLAG Therapeutics General Information


Operator of an oncology company intended to develop a dual-acting small molecule for the treatment of Glioblastoma. The company's therapies are based on two investigational product platforms--the Anti-angiogenic/Anti-tubulin (AA/AT) platform and Folate-target Anti-cancer (FTAC) platform that include multiple water-soluble small molecule compounds, enabling doctors to treat multiple cancer types including brain, lung, ovarian and pancreatic.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 9168 Wooden Road
  • Raleigh, NC 27617
  • United States
+1 (919) 000-0000

FLAG Therapeutics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FLAG Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Jul-2019 $72.5K 00.000 Completed Generating Revenue
3. Seed Round 09-Jan-2019 00.00 00.000 000.00 Completed Startup
2. Grant 01-Jan-2017 $1.5M $250K Completed Startup
1. Debt - General 06-Mar-2015 $250K $250K Completed Startup
To view FLAG Therapeutics’s complete valuation and funding history, request access »

FLAG Therapeutics Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.0 00.0 00 00.0 00.00
To view FLAG Therapeutics’s complete cap table history, request access »

FLAG Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Frank Sorgi Ph.D Founder, President & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

FLAG Therapeutics Board Members (1)

Name Representing Role Since
Frank Sorgi Ph.D FLAG Therapeutics Founder, President & Chief Executive Officer 000 0000
To view FLAG Therapeutics’s complete board members history, request access »

FLAG Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FLAG Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view FLAG Therapeutics’s complete investors history, request access »